Testing effectiveness (Phase 2)Study completedNCT05348811What this trial is testingHAIC Combined With Donafenib and Sintilimab for Unresectable ICCWho this might be right forCholangiocarcinoma Zhongda Hospital 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT04175912What this trial is testingTesting the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the LiverWho this might be right forMetastatic CholangiocarcinomaMetastatic Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v8+12 more National Cancer Institute (NCI) 40
Early research (Phase 1)Looking for participantsNCT06160752What this trial is testingSafety and Anti-Tumor Activity of TYRA-200 in Advanced Cholangiocarcinoma With Activating FGFR2 Gene AlterationsWho this might be right forLocally Advanced CholangiocarcinomaIntrahepatic CholangiocarcinomaSolid Tumor+1 more Tyra Biosciences, Inc 40
Not applicableLooking for participantsNCT04556214What this trial is testingLiver Transplantation for Non-Resectable Intrahepatic Cholangiocarcinoma: a Prospective Exploratory Trial (TESLA Trial)Who this might be right forIntrahepatic Cholangiocarcinoma Oslo University Hospital 15
Testing effectiveness (Phase 2)Study completedNCT00553332What this trial is testingSelumetinib in Treating Patients With Biliary Cancer That Cannot Be Removed By SurgeryWho this might be right forLiver and Intrahepatic Biliary Tract CancerRecurrent Extrahepatic Bile Duct CancerUnresectable Extrahepatic Bile Duct Cancer National Cancer Institute (NCI) 29
Not applicableNot Yet RecruitingNCT06539377What this trial is testingLiving Donor Liver Transplantation for Intrahepatic CholangiocarcinomaWho this might be right forLiving Donor Liver TransplantationLiver TransplantationNeoadjuvant Therapy Jena University Hospital 6
Testing effectiveness (Phase 2)Looking for participantsNCT06852287What this trial is testingPhase II Clinical Study of GemOX Hepatic Arterial Infusion Combined with Lenvatinib and Toripalimab for Advanced and Unresectable Intrahepatic Cholangiocarcinoma and Gallbladder CancerWho this might be right forIntrahepatic Cholangiocarcinoma (Icc)Gall Bladder Cancer Tianjin Medical University Cancer Institute and Hospital 33
Not applicableEnrolling By InvitationNCT04195503What this trial is testingLiver Transplant for Stable, Advanced Intrahepatic CholangiocarcinomaWho this might be right forCholangiocarcinoma, Intrahepatic University Health Network, Toronto 10
Large-scale testing (Phase 3)Looking for participantsNCT05342194What this trial is testingToripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC: a Phase III StudyWho this might be right forIntrahepatic Cholangiocarcinoma Shanghai Junshi Bioscience Co., Ltd. 480
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07353827What this trial is testingFOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic CholangiocarcinomaWho this might be right forIntrahepatic Cholangiocarcinoma (Icc)Hepatic Arterial Infusion Chemotherapy Sun Yat-sen University 36
Early research (Phase 1)Active Not RecruitingNCT04491942What this trial is testingTesting the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial CancerWho this might be right forAdvanced Bile Duct CarcinomaAdvanced Breast CarcinomaAdvanced Cervical Carcinoma+31 more National Cancer Institute (NCI) 74
Testing effectiveness (Phase 2)Looking for participantsNCT05678270What this trial is testingICP-192 in Patients With FGFR2-Rearranged Unresectable or Metastatic Intrahepatic CholangiocarcinomaWho this might be right forIntrahepatic Cholangiocarcinoma (ICC) Beijing InnoCare Pharma Tech Co., Ltd. 70
Not applicableLooking for participantsNCT06505486What this trial is testingGEMOX-HAIC Plus GEM-SYS in Combination With Lenvatinib and PD-1 Inhibitor for Large Unresectable ICCWho this might be right forIntrahepatic Cholangiocarcinoma Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 21
Testing effectiveness (Phase 2)UnknownNCT05290116What this trial is testingHAIC Combined With Tislelizumab and Apatinib for Unresectable Intrahepatic CholangiocarcinomaWho this might be right forIntrahepatic Cholangiocarcinoma Yunfei Yuan 17
Early research (Phase 1)Looking for participantsNCT06058663What this trial is testingRadioembolization With Tremelimumab and Durvalumab for Locally Advanced Unresectable or Oligo-Metastatic Intrahepatic CholangiocarcinomaWho this might be right forLocally Advanced Intrahepatic CholangiocarcinomaOligometastatic Intrahepatic CholangiocarcinomaStage III Intrahepatic Cholangiocarcinoma AJCC v8+2 more Mayo Clinic 16
Testing effectiveness (Phase 2)UnknownNCT05400902What this trial is testingHAIC Combined With Sintilimab and Bevacizumab for Unresectable Intrahepatic CholangiocarcinomaWho this might be right forIntrahepatic Cholangiocarcinoma Binkui Li 17
Not applicableUnknownNCT02238613What this trial is testingRadioactive Stents for Treatment of Unresectable Biliary Tract CancerWho this might be right forIntrahepatic CholangiocarcinomaCholangiocarcinoma of the Extrahepatic Bile DuctAmpullary Carcinoma+1 more 307 Hospital of PLA 140
Large-scale testing (Phase 3)UnknownNCT03771846What this trial is testingHAIC Versus Systemic Chemotherapy for Unresectable ICCWho this might be right forIntrahepatic Cholangiocarcinoma Shi Ming 188
Testing effectiveness (Phase 2)Ended earlyNCT02994251What this trial is testingA Trial of Systemic Chemotherapy in Combination With Conventional Transarterial Chemoembolization in Patients With Advanced Intra-Hepatic CholangiocarcinomaWho this might be right forUnresectable Intrahepatic Cholangiocarcinoma Yale University 1
Testing effectiveness (Phase 2)Study completedNCT04361331What this trial is testingTwo-cohort Study of Toripalimab(PD1)+Lenvatnib, or Gemox+Lenvatinib in Advanced Intrahepatic CholangiocarcinomaWho this might be right forCholangiocarcinoma, Intrahepatic Shanghai Zhongshan Hospital 61